Transaction in Own Shares

PureTech Health PLC

03 January 2024

 

3 January 2024

PureTech Health plc

Transaction in Own Shares

PureTech Health PLC (the "Company") announces that it has purchased the following number of its ordinary shares of one pence each through Jefferies International Limited ("Jefferies"), as part of its Share Buyback Programme, details of which were announced on 9 May 2022.

Date of purchase:	2 January 2024
Number of ordinary shares purchased:	12,161
Highest price paid per share:	188.00p
Lowest price paid per share:	186.20p
Volume weighted average price paid per share:	187.73p

PureTech intends to retain the purchased shares in treasury.

Following the above transaction, the Company will have 17,626,589 ordinary shares in treasury and has 271,841,570 ordinary shares in issue (excluding treasury shares). The total number of voting rights in the Company is therefore 271,841,570 which may be used by shareholders in their calculations to determine if they are required to notify their interest in, or a change to their interest in, PureTech Health plc under the FCA's Disclosure Guidance and Transparency Rules.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) (the Market Abuse Regulation), detailed information about the individual purchases is available below.

About PureTech Health

PureTech is a clinical-stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company has created a broad and deep pipeline through its experienced research and development team and its extensive network of scientists, clinicians and industry leaders that is being advanced both internally and through its Founded Entities. PureTech's R&D engine has resulted in the development of 27 therapeutics and therapeutic candidates, including two (Plenity® and EndeavorRx®) that have received both U.S. FDA clearance and European marketing authorization and a third (KarXT) that has been filed for FDA approval. A number of these programs are being advanced by PureTech or its Founded Entities in various indications and stages of clinical development, including registration enabling studies. All of the underlying programs and platforms that resulted in this pipeline of therapeutic candidates were initially identified or discovered and then advanced by the PureTech team through key validation points.

For more information, visit www.puretechhealth.com or connect with us on X, formerly known as Twitter, @puretechh.

Contact:

PureTech

Investor Relations

[e-mail]

Individual Transactions

Transaction Date	Transaction Time	Volume	Price (GBp)	Platform	Transaction Reference Number
02/01/2024	09:18:34	22	188	CHIX	00383801337TRLO0.1.1
02/01/2024	09:18:34	484	188	CHIX	00383801338TRLO0.1.1
02/01/2024	09:18:34	286	188	BATE	00383801340TRLO0.1.1
02/01/2024	09:18:34	174	188	BATE	00383801339TRLO0.1.1
02/01/2024	09:18:34	59	188	TRQX	00383801341TRLO0.1.1
02/01/2024	09:18:34	155	188	TRQX	00383801342TRLO0.1.1
02/01/2024	09:18:34	1012	188	XLON	00383801344TRLO0.1.1
02/01/2024	09:18:34	61	188	TRQX	00383801343TRLO0.1.1
02/01/2024	09:18:34	101	188	TRQX	00383801345TRLO0.1.1
02/01/2024	11:56:28	501	188	AQXE	00383822624TRLO0.1.1
02/01/2024	11:56:28	456	188	AQXE	00383822625TRLO0.1.1
02/01/2024	11:56:28	506	188	CHIX	00383822626TRLO0.1.1
02/01/2024	11:56:28	45	188	AQXE	00383822627TRLO0.1.1
02/01/2024	11:56:28	506	188	BATE	00383822629TRLO0.1.1
02/01/2024	11:56:28	46	188	BATE	00383822628TRLO0.1.1
02/01/2024	11:56:28	174	188	TRQX	00383822630TRLO0.1.1
02/01/2024	11:56:28	506	188	XLON	00383822631TRLO0.1.1
02/01/2024	11:56:28	506	188	XLON	00383822632TRLO0.1.1
02/01/2024	11:56:28	506	188	XLON	00383822633TRLO0.1.1
02/01/2024	12:08:00	1012	187.2	XLON	00383824162TRLO0.1.1
02/01/2024	12:46:17	94	188	CHIX	00383827576TRLO0.1.1
02/01/2024	12:46:17	412	188	CHIX	00383827577TRLO0.1.1
02/01/2024	12:46:17	208	188	XLON	00383827578TRLO0.1.1
02/01/2024	12:46:17	804	188	XLON	00383827579TRLO0.1.1
02/01/2024	12:46:21	216	187.6	BATE	00383827580TRLO0.1.1
02/01/2024	13:12:45	290	187.6	BATE	00383830138TRLO0.1.1
02/01/2024	13:12:45	275	187.6	TRQX	00383830139TRLO0.1.1
02/01/2024	13:12:45	506	187.4	XLON	00383830140TRLO0.1.1
02/01/2024	13:12:45	274	187.4	XLON	00383830142TRLO0.1.1
02/01/2024	13:12:45	506	187.4	XLON	00383830141TRLO0.1.1
02/01/2024	13:12:45	232	187.4	XLON	00383830143TRLO0.1.1
02/01/2024	13:12:46	318	186.6	CHIX	00383830144TRLO0.1.1
02/01/2024	13:12:46	188	186.6	CHIX	00383830145TRLO0.1.1
02/01/2024	13:12:46	44	186.6	CHIX	00383830146TRLO0.1.1
02/01/2024	13:12:46	56	186.6	CHIX	00383830147TRLO0.1.1
02/01/2024	13:21:49	214	186.2	XLON	00383831055TRLO0.1.1
02/01/2024	13:52:40	406	188	CHIX	00383834671TRLO0.1.1

 

END